NL8103784A - Farmaceutische preparaten; bereidingsmethode. - Google Patents

Farmaceutische preparaten; bereidingsmethode. Download PDF

Info

Publication number
NL8103784A
NL8103784A NL8103784A NL8103784A NL8103784A NL 8103784 A NL8103784 A NL 8103784A NL 8103784 A NL8103784 A NL 8103784A NL 8103784 A NL8103784 A NL 8103784A NL 8103784 A NL8103784 A NL 8103784A
Authority
NL
Netherlands
Prior art keywords
cisplatin
microcrystalline
sterile
concentration
microcrystalline cisplatin
Prior art date
Application number
NL8103784A
Other languages
English (en)
Dutch (nl)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL8103784A publication Critical patent/NL8103784A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G55/00—Compounds of ruthenium, rhodium, palladium, osmium, iridium, or platinum
    • C01G55/002—Compounds containing, besides ruthenium, rhodium, palladium, osmium, iridium, or platinum, two or more other elements, with the exception of oxygen or hydrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/74—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by peak-intensities or a ratio thereof only
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/51—Particles with a specific particle size distribution
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00—Particle morphology
    • C01P2004/60—Particles characterised by their size
    • C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/80—Compositional purity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
NL8103784A 1979-10-02 1981-08-12 Farmaceutische preparaten; bereidingsmethode. NL8103784A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8130179 1979-10-02
US06/081,301 US4302446A (en) 1979-10-02 1979-10-02 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
NL8103784A true NL8103784A (nl) 1983-03-01

Family

ID=22163311

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8103784A NL8103784A (nl) 1979-10-02 1981-08-12 Farmaceutische preparaten; bereidingsmethode.

Country Status (12)

Country Link
US (2) US4302446A (sv)
JP (1) JPS5832029A (sv)
AT (1) AT375326B (sv)
AU (1) AU551710B2 (sv)
BE (1) BE890192A (sv)
CA (1) CA1152289A (sv)
CH (1) CH647216A5 (sv)
DE (1) DE3133443A1 (sv)
FR (1) FR2511357B1 (sv)
GB (1) GB2103591B (sv)
NL (1) NL8103784A (sv)
SE (2) SE450830B (sv)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
DE3305248A1 (de) * 1983-02-16 1984-08-16 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung von reinem cis-platin-(ii)-diammin-dichlorid
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
US4699978A (en) * 1985-01-18 1987-10-13 The Trustees Of Columbia University In The City Of New York Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents
US4686104A (en) * 1985-04-30 1987-08-11 Sloan-Kettering Institute For Cancer Research Methods of treating bone disorders
JPS61293655A (ja) * 1985-05-31 1986-12-24 Trinity Ind Corp 砂型鋳造品の砂落し装置
CS269719B1 (en) * 1986-12-29 1990-05-14 Kiss Frantisek Platinum cytostatic
JP2657393B2 (ja) * 1988-05-18 1997-09-24 日本化薬株式会社 化学塞栓療法剤
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
US4946689A (en) * 1988-11-23 1990-08-07 Bristol-Myers Company Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin
US8728536B2 (en) * 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
US6251355B1 (en) 1996-12-25 2001-06-26 Nippon Kayaku Kabushiki Kaisha Fine cisplatin powder and process for the production thereof
US6074626A (en) * 1998-03-20 2000-06-13 Molecular Radiation Management, Inc. Radioactive cisplatin in the treatment of cancer
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
EP1541146B1 (en) 2000-04-24 2006-12-20 Teva Pharmaceutical Industries Ltd. Zolpidem hemitartrate solvate
KR20030069796A (ko) * 2000-04-24 2003-08-27 테바 파마슈티컬 인더스트리즈 리미티드 졸피뎀 헤미타르트레이트
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
CN1589149A (zh) * 2001-09-24 2005-03-02 托斯克公司 减低毒性的顺铂制剂及其使用方法
ATE477193T1 (de) * 2003-03-15 2010-08-15 Brin Tech Internat Ltd Verpackung für arzneimittel
JP2006521300A (ja) * 2003-03-31 2006-09-21 プリヴァ−ラケマ，エー．エス． 活性物質として白金錯体を含有する医薬組成物およびその製造方法
CA2542499A1 (en) * 2003-10-16 2005-04-28 Teva Pharmaceutical Industries Ltd. Preparation of candesartan cilexetil
ATE387203T1 (de) * 2004-01-05 2008-03-15 Teva Pharma Prozesse zur herstellung von sildenafil-base und zitratsalz
US7692023B2 (en) * 2004-02-11 2010-04-06 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
US20080085882A1 (en) * 2006-08-18 2008-04-10 University Of North Texas Health Science Center At Fort Worth Compositions and Methods for Potentiation of Cancer Agents
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) * 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
AU2008214199A1 (en) * 2007-02-09 2008-08-14 Poniard Pharmaceuticals, Inc. Encapsulated picoplatin
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
EP2178893A4 (en) * 2007-07-16 2012-09-19 Poniard Pharmaceuticals Inc ORAL FORMULATIONS FOR PICOPLATIN
CN102014624A (zh) * 2008-02-08 2011-04-13 帕纳德制药公司 治疗肺癌的吡铂和氨柔比星
JP5694782B2 (ja) 2008-03-14 2015-04-01 バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド 肺癌、腺癌及び他の病状のための治療方法及び組成物
WO2009113989A1 (en) 2008-03-14 2009-09-17 Bionumerik Pharmaceuticals, Inc. Compositions and methods of use of compounds to increase cancer patient survival time
US20100035853A1 (en) * 2008-08-07 2010-02-11 Hyogo College Of Medicine Method for preventing or treating cisplatin-induced nephrotoxicity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079121A (en) * 1974-12-13 1978-03-14 Mobil Oil Corporation Complexes of beta platinum chloride and ammonia
CA1119954A (en) * 1978-05-30 1982-03-16 Edmund S. Granatek Aqueous solution of cisplatin
US4273755A (en) * 1979-08-16 1981-06-16 Mpd Technology Corporation Preparation of platinum complexes

Also Published As

Publication number Publication date
AU551710B2 (en) 1986-05-08
AT375326B (de) 1984-07-25
JPH0313174B2 (sv) 1991-02-21
US4302446A (en) 1981-11-24
SE8300623L (sv) 1983-02-07
GB2103591B (en) 1985-03-06
CH647216A5 (de) 1985-01-15
JPS5832029A (ja) 1983-02-24
SE8104661L (sv) 1983-02-04
SE455469B (sv) 1988-07-18
GB2103591A (en) 1983-02-23
FR2511357B1 (fr) 1986-09-05
ATA374981A (de) 1983-12-15
SE450830B (sv) 1987-08-03
FR2511357A1 (fr) 1983-02-18
CA1152289A (en) 1983-08-23
AU7390681A (en) 1983-02-10
BE890192A (fr) 1982-03-02
US4322391A (en) 1982-03-30
DE3133443A1 (de) 1983-03-10
SE8300623D0 (sv) 1983-02-07

Similar Documents

Publication Publication Date Title
NL8103784A (nl) Farmaceutische preparaten; bereidingsmethode.
US4748174A (en) Water soluble salts of an NSAID with meglumine/glucamine
ES2257038T3 (es) Metodos y composiciones para la administracion de taxanos.
CA2766291A1 (en) Injectable formulations containing asenapine and method of treatment using same
DE3333024A1 (de) Neue pharmakologische zusammensetzungen auf basis von cis-platin und verfahren zu deren herstellung
KR880002087B1 (ko) 항균성 나프티리딘 또는 퀴놀린 화합물의 염 및 그의 제조방법
CN102140079B (zh) 新乌碱及其制备方法和以该化合物为活性成分的药物组合物及用途
HUE030221T2 (en) Solid pharmaceutical composition containing biopterin derivatives and uses of such compositions
CN102600070B (zh) 环磷腺苷葡胺组合物注射液及其制备方法
DE2906700A1 (de) Pharmazeutisches mittel
CN101919816B (zh) 一种含有替加环素的注射用无菌分装制剂
HU183379B (en) Process for producing stabil, concentrated cisplatine solutions
DE69627209T2 (de) Lyophilisiertes thioxanthenon-antitumormedikament
EP0944612B1 (en) N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate
FI72302C (sv) Förfarande för framställning av stabilt mikrokristallint cisplatin.
CN103073617A (zh) N(2)-l-丙氨酰-l-谷氨酰胺的化合物
IE51468B1 (en) Microcrystalline cisplatin and formulations containing it
Levy et al. DETERIORATION OF CRYSTALLINE STROPHANTHIN IN AQUEOUS SOLUTION: Its Relation to Hydrogen Ion Concentration and a Method for Its Prevention.
CS269719B1 (en) Platinum cytostatic
DK157484B (da) Fremgangsmaade til fremstilling af et cisplatin-praeparat
US4946689A (en) Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin
CZ8095A3 (en) Hydrochloride of ng-monomethyl-l-arginine, process of its preparation, pharmaceutical composition containing thereof and its use in medicine
RU2216332C1 (ru) Лечебный препарат для лечения артроза
KR960002182B1 (ko) 향지성제
RU2054286C1 (ru) Платиновый цитостатик и способ его получения

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BV The patent application has lapsed